ABSI

NASDAQ · Biotechnology

Absci Corp

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.93

+0.63 (+7.59%)

As of Aug 9, 10:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +163.7% upside

Low Target $16.79

Average Target $23.55

High Target $35.63

Current Price $8.93

Current
$8.93

Target
$23.55

$16.79 $23.55 avg $35.63

Scenario Analysis

Bear Case

$16.79

88.0%

Low target

Base Case

$23.55

+163.7%

Avg target

Bull Case

$35.63

+299.0%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$12.06

-25.9% from high

52-Week Low

$2.24

+298.7% from low

Target vs 52W High

$23.55

+95.4% vs high

Next Earnings Report

Aug 11, 2026 · After Market Close

Today

EPS Est: $-0.21

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%